Described herein are methods and compositions for inhibiting, treating and reversing intervertebral disc disorders using transcription factor inhibitors. In certain embodiments, the transcription factor inhibitor targets the transcription factor NF-.kappa.B. Also described are methods and compositions where intervertebral disc disorder is reversed using a decoy oligodeoxy-nucleotide that blocks NF-.kappa.B.

 
Web www.patentalert.com

< Estrogen related receptor, ERR.alpha., a regulator of bone formation

> Interbody cage system

> Biomarkers for oral tongue cancer metastasis and extracapsular spread (ECS)

~ 00544